220 related articles for article (PubMed ID: 32523531)
1. Identification of a Pharmacological Biomarker for the Bioassay-Based Quality Control of a Thirteen-Component TCM Formula (Lianhua Qingwen) Used in Treating Influenza A Virus (H1N1) Infection.
Gao D; Niu M; Wei SZ; Zhang CE; Zhou YF; Yang ZW; Li L; Wang JB; Zhang HZ; Zhang L; Xiao XH
Front Pharmacol; 2020; 11():746. PubMed ID: 32523531
[TBL] [Abstract][Full Text] [Related]
2. Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen).
Chen S; Yang X; Wei Z; Zhang Y; Huang Y; Shi Z; Zhang Z; Wang J; Zhang H; Ma J; Xiao X; Niu M
Pharm Biol; 2021 Dec; 59(1):537-545. PubMed ID: 33941036
[TBL] [Abstract][Full Text] [Related]
3. Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus.
Xu P; Yang Z; Du S; Hong Z; Zhong S
Front Microbiol; 2022; 13():1035941. PubMed ID: 36504796
[TBL] [Abstract][Full Text] [Related]
4. The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis.
Hu C; He B; Gong F; Liang M; Zhao D; Zhang G
Front Pharmacol; 2022; 13():764774. PubMed ID: 35153773
[No Abstract] [Full Text] [Related]
5. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
[TBL] [Abstract][Full Text] [Related]
6. Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration.
Li S; Feng T; Zhang Y; Shi Q; Wang W; Ren J; Shen G; Gu H; Luo C; Li Y
J Ethnopharmacol; 2024 Feb; 320():117467. PubMed ID: 37981112
[TBL] [Abstract][Full Text] [Related]
7. High-quality trials and pharmacological studies needed as translational evidence for the application of traditional Chinese medicine Lianhua Qingwen against COVID-19.
Huang N; Li S
Phytother Res; 2022 Dec; 36(12):4295-4298. PubMed ID: 35915552
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach.
Yang R; Yang H; Wei J; Li W; Yue F; Song Y; He X; Hu K
Front Pharmacol; 2021; 12():717652. PubMed ID: 34721017
[No Abstract] [Full Text] [Related]
9. Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model.
Yang C; Wang Y; He J; Yan W; Jiang H; Chen Q; Li L; Yang Z
Evid Based Complement Alternat Med; 2020; 2020():3196375. PubMed ID: 32565852
[TBL] [Abstract][Full Text] [Related]
10. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.
Li L; Wang X; Guo X; Li Y; Song Q; Li A
Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Lianhua Qingwen for Patients with COVID-19: A Systematic Review and Meta-Analysis.
Sun XH; Zhang S; Yang Z; Chen ZL; Yue SJ; Zhang S; Tang YP
Chin J Integr Med; 2022 Jul; 28(7):650-660. PubMed ID: 35776293
[TBL] [Abstract][Full Text] [Related]
12. Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS.
Fu S; Cheng R; Deng Z; Liu T
J Pharm Anal; 2021 Dec; 11(6):709-716. PubMed ID: 35028175
[TBL] [Abstract][Full Text] [Related]
13. Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms.
Huang K; Zhang P; Zhang Z; Youn JY; Wang C; Zhang H; Cai H
Pharmacol Ther; 2021 Sep; 225():107843. PubMed ID: 33811957
[TBL] [Abstract][Full Text] [Related]
14. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.
Hong L; He M; Li S; Zhao J
Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].
Li Q; Yin J; Ran QS; Yang Q; Liu L; Zhao Z; Li YJ; Chen Y; Sun LD; Wang YJ; Weng XG; Cai WY; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2317-2323. PubMed ID: 31359658
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of Lianhua Qingwen capsule for influenza： a systematic review].
Niu QQ; Chen Y; Liu Y; Mao SZ; Wang H; Zheng WK; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1474-1481. PubMed ID: 29071849
[TBL] [Abstract][Full Text] [Related]
17. [Innovation of traditional Chinese medicine compounds and patent layout strategy with Lianhua Qingwen Formula as example].
Li WH; Li YH; Shan XG
Zhongguo Zhong Yao Za Zhi; 2021 Mar; 46(5):1293-1300. PubMed ID: 33787125
[TBL] [Abstract][Full Text] [Related]
18. [Systematic review of efficacy and safety of Lianhua Qingwen Capsules in treatment of viral influenza].
Wang SH; Liu JF; Zhang YL; Dong Z
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1503-1508. PubMed ID: 31090311
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive characterization of the chemical constituents of Lianhua Qingwen capsule by ultra high performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry.
Liu T; Lin S
Heliyon; 2024 Mar; 10(6):e27352. PubMed ID: 38496865
[TBL] [Abstract][Full Text] [Related]
20. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening.
Chen X; Wu Y; Chen C; Gu Y; Zhu C; Wang S; Chen J; Zhang L; Lv L; Zhang G; Yuan Y; Chai Y; Zhu M; Wu C
Acta Pharm Sin B; 2021 Jan; 11(1):222-236. PubMed ID: 33072499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
